About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, headquartered at 450 Brookline Avenue in Boston, Massachusetts, is a leading institution dedicated to the fight against cancer. Renowned for its expert and compassionate care, Dana-Farber serves both children and adults, offering a comprehensive range of services that encompass cancer treatment, research, and prevention. The institute is at the forefront of oncology, providing cutting-edge therapies and innovative clinical trials that leverage the latest advancements in cancer research.
Dana-Farber specializes in various cancer types, including but not limited to breast, lung, prostate, and pediatric cancers, ensuring that patients receive tailored treatment plans that meet their unique needs. The institute employs a multidisciplinary approach, integrating medical oncology, radiation therapy, surgical oncology, and supportive care services to enhance patient outcomes and quality of life.
In addition to its clinical services, Dana-Farber is deeply committed to advancing cancer research. The institute collaborates with other leading research organizations and utilizes state-of-the-art technologies, such as genomics and immunotherapy, to explore new avenues for cancer treatment and prevention. Through its robust research programs, Dana-Farber aims to translate scientific discoveries into effective therapies, ultimately striving to find cures for cancer and related diseases.
With a mission centered on patient care and groundbreaking research, Dana-Farber Cancer Institute stands as a beacon of hope for those affected by cancer, embodying a commitment to excellence in the fight against this complex disease.
|
|
|
5,001-10,000 employees
View all Dana-Farber Cancer Institute employees
|
|
Hospital & Health Care
|
|
450 Brookline Avenue, Boston, MA 02215, US
|
|
1947
|
|
Research, Technology, Innovation, Patient Services, Adult Cancer Treatment, Aids Research, Cancer Research, Pediatric Cancer Treatment, Adult Cancer Treatment, Aids Research, Cancer Research, Innovation, Research, Patient Services, Pediatric Cancer Treatment, Technology
|
Dana-Farber Cancer Institute Alternatives
Frequently Asked Questions about Dana-Farber Cancer Institute
Adelaide Donnelly is the CEO of Dana-Farber Cancer Institute. To contact Adelaide Donnelly email at [email protected] or [email protected].
The decision makers in Dana-Farber Cancer Institute are Edward J Benz, Holly V Berteau, Hugh Kelleher, etc. Click to Find Dana-Farber Cancer Institute decision makers emails.
Dana-Farber Cancer Institute Staff Directory
Search Dana-Farber Cancer Institute Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
